140 related articles for article (PubMed ID: 16267602)
1. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Tanabe N; Harada T; Murakami S; Hasegawa H; Sakatsume M; Nakano M; Gejyo F
Clin Rheumatol; 2006 Jul; 25(4):498-505. PubMed ID: 16267602
[TBL] [Abstract][Full Text] [Related]
2. Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis.
Kuroda T; Tanabe N; Nozawa Y; Sato H; Nakatsue T; Kobayashi D; Wada Y; Saeki T; Nakano M; Narita I
Intern Med; 2016; 55(19):2777-2783. PubMed ID: 27725536
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment.
Kuroda T; Tanabe N; Sato H; Ajiro J; Wada Y; Murakami S; Hasegawa H; Sakatsume M; Nakano M; Gejyo F
Rheumatol Int; 2006 Oct; 26(12):1147-53. PubMed ID: 16953393
[TBL] [Abstract][Full Text] [Related]
4. Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Sakatsume M; Nakano M; Narita I
Rheumatol Int; 2011 Sep; 31(9):1177-82. PubMed ID: 20349236
[TBL] [Abstract][Full Text] [Related]
5. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Saeki T; Nakano M; Narita I
J Rheumatol; 2012 Jul; 39(7):1348-54. PubMed ID: 22589255
[TBL] [Abstract][Full Text] [Related]
6. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
[TBL] [Abstract][Full Text] [Related]
7. Renal amyloidosis is associated with increased mortality in hemodialysis patients.
Sengul S; Arat Z; Ozdemir FN
Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948
[TBL] [Abstract][Full Text] [Related]
8. Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis.
Sanai T; Nanishi F; Nagata M; Hirano T; Suematsu E; Esaki Y; Miyahara H; Iida M
Rheumatol Int; 2007 Feb; 27(4):363-7. PubMed ID: 17013609
[TBL] [Abstract][Full Text] [Related]
9. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
Ueno T; Takeda K; Nagata M
Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
[TBL] [Abstract][Full Text] [Related]
10. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide.
Chevrel G; Jenvrin C; McGregor B; Miossec P
Rheumatology (Oxford); 2001 Jul; 40(7):821-5. PubMed ID: 11477289
[TBL] [Abstract][Full Text] [Related]
11. Amyloidosis is frequently undetected in patients with rheumatoid arthritis.
Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M
Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and survival in AA amyloidosis patients.
Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
[TBL] [Abstract][Full Text] [Related]
13. Amyloidosis as a cause of death in patients with rheumatoid arthritis.
Koivuniemi R; Paimela L; Suomalainen R; Leirisalo-Repo M
Clin Exp Rheumatol; 2008; 26(3):408-13. PubMed ID: 18578961
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and survival of secondary (AA) amyloidosis.
Tanaka F; Migita K; Honda S; Fukuda T; Mine M; Nakamura T; Yamasaki S; Ida H; Kawakami A; Origuchi T; Eguchi K
Clin Exp Rheumatol; 2003; 21(3):343-6. PubMed ID: 12846054
[TBL] [Abstract][Full Text] [Related]
15. [Lethal complications and associated diseases of rheumatoid arthritis--a retrospective clinicopathologic study of 234 autopsy patients].
Bély M; Apáthy A
Orv Hetil; 2006 Jun; 147(23):1063-76. PubMed ID: 16856508
[TBL] [Abstract][Full Text] [Related]
16. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
Gertz MA; Kyle RA; O'Fallon WM
Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
[TBL] [Abstract][Full Text] [Related]
17. [Cause of death in autopsied RA patients].
Toyoshima H; Kusaba T; Yamaguchi M
Ryumachi; 1993 Jun; 33(3):209-14. PubMed ID: 8346462
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of thirty-four rheumatoid arthritis patients with renal amyloidosis, including twelve given alkylating agents.
Couverchel L; Maugars Y; Prost A
Rev Rhum Engl Ed; 1995 Feb; 62(2):79-85. PubMed ID: 7600076
[TBL] [Abstract][Full Text] [Related]
19. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
20. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis.
Okuda Y; Takasugi K; Oyama T; Oyama H; Nanba S; Miyamoto T
Ann Rheum Dis; 1997 Sep; 56(9):535-41. PubMed ID: 9370878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
